Novartis India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Novartis India Ltd. on BSE

Search Inside the pdf :

Novartis India Ltd.

30 Jul 2025, 08:09PM

975.80

-2.00%

Company Update

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation of the publication of Financial Results for the quarter ended June 30, 2025 in the Newspaper - Financial Express (English) and Navshakti (Marathi).

pdf

Novartis India Ltd.

29 Jul 2025, 06:26PM

975.80

-2.00%

Company Update

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation of the approval of the Board of Directors for the Appointment of Cost Auditor for the Financial Year 2025-26

pdf

Novartis India Ltd.

29 Jul 2025, 05:10PM

975.80

-2.00%

Result

Novartis India Ltd - 500672 - Unaudited Financial Results For The Quarter Ended As On June …

BSE India

Intimation for the Unaudited Financial Results for the Quarter ended as on June 30, 2025.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	98.16	94.51	102.70	3.9%	-4.4%
Operating Profit Qtr	27.24	23.91	23.97	13.9%	13.6%
Net Profit Qtr	27.62	29.30	25.74	-5.7%	7.3%
Earning Per Share Adjusted latest Qtr	11.19	11.87	10.42	-5.7%	7.4%

* Standalone data

Detailed Results

Novartis India Ltd.

29 Jul 2025, 04:37PM

975.80

-2.00%

Board Meeting

Novartis India Ltd - 500672 - Board Meeting Outcome for Intimation About The Outcome Of The …

BSE India

Intimation about the Outcome of the Board Meeting held on July 29, 2025, inter alia for the approval of the unaudited Financial Statements for the Quarter ending as on June 30, 2025.

pdf

Novartis India Ltd.

14 Jul 2025

975.80

-2.00%

Company Update

Novartis India Ltd - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Intimation of the Certificate dated July 10, 2025, received from RTA under Regulation 74(5) of SEBI (DP) Regulations, 2018

pdf

Novartis India Ltd.

11 Jul 2025

975.80

-2.00%

Company Update

Novartis India Ltd - 500672 - Intimation About The 77Th Annual General Meeting ("AGM") And Weblink …

BSE India

Intimation about the 77th Annual General Meeting ("AGM") and Weblink of Anuual Report for F.Y 2024-25 of Novartis India Limited ( "The Company") to the shareholders by way of physical dispatch of letters.

pdf

Novartis India Ltd.

06 Jul 2025

975.80

-2.00%

Company Update

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

This intimation is submitted for filing the advertisement post the dispatch of Notice of AGM to the Shareholders.

pdf

Novartis India Ltd.

04 Jul 2025

975.80

-2.00%

Corp. Note

Novartis India Ltd - 500672 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

This intimation is submitted for filing the Business Responsibility and Sustainability Report (''BRSR'') for F.Y 2024-25 which also forms a part of Annual Report of the Company for F.Y 2024-25.

pdf

Novartis India Ltd.

04 Jul 2025

975.80

-2.00%

Corp. Note

Novartis India Ltd - 500672 - Reg. 34 (1) Annual Report.

BSE India

The Annual Report for the Financial Year 2024-25 is sent to the shareholders on July 04, 2025 and BSE is hereby intimated about the same.

pdf

Novartis India Ltd.

04 Jul 2025

975.80

-2.00%

AGM

Novartis India Ltd - 500672 - 77Th Annual General Meeting Of Novartis India Limited To Be …

BSE India

Intimation is given that the 77th Annual General Meeting of Novartis India Limited is scheduled to be held on Thursday, July 31, 2025, through Video Conferencing (VC) / Other Audio Visual Means (OAVM)

pdf

Is Novartis India Ltd. worth buying?

70 Votes:

Buy 74.29%

Sell 15.71%

Hold 10.0%